Joint Filing Agreement
Exhibit 99.1
The undersigned hereby agree that the Statement on Schedule 13G dated February 17, 2021 with respect to the shares of Common Stock of GT Biopharma, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: February 17, 2021
Bigger Capital Fund, LP | Bigger Capital Fund GP, LLC | |||
By: | Bigger Capital Fund GP, LLC, its general partner | By: |
/s/ Xxxxxxx Xxxxxx | |
Xxxxxxx Xxxxxx | ||||
By: |
/s/ Xxxxxxx Xxxxxx |
Managing Member | ||
Xxxxxxx Xxxxxx | ||||
Managing Member | ||||
District 2 Capital LP | ||||
District 2 Capital Fund LP | By: |
/s/ Xxxxxxx Xxxxxx | ||
Xxxxxxx Xxxxxx | ||||
By: | District 2 GP LLC, its general partner | Managing Member | ||
By: |
/s/ Xxxxxxx Xxxxxx |
|||
Xxxxxxx Xxxxxx | District 2 Holdings LLC | |||
Managing Member | ||||
By: |
/s/ Xxxxxxx Xxxxxx | |||
Xxxxxxx Xxxxxx | ||||
District 2 GP LLC | Managing Member | |||
By: |
/s/ Xxxxxxx Xxxxxx |
|||
Xxxxxxx Xxxxxx |
/s/ Xxxxxxx Xxxxxx | |||
Managing Member | Xxxxxxx Xxxxxx |